Friedreich ataxia Trials in Philadelphia, United States
Conditions / Friedreich ataxia / Philadelphia, United States
Friedreich ataxia has been the subject of sustained clinical investigation across multiple research sites.
19 total trials for this combination
Showing top 10 of 19 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06016946 | Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study | RECRUITING | — |
| NCT05515536 | A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich Ataxia | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04349514 | A Natural History Study to TRACK Brain and Spinal Cord Changes in Individuals with Friedreich Ataxia (TRACK-FA) | ACTIVE_NOT_RECRUITING | — |
| NCT03214588 | Efficacy, Tolerability, and Pharmacokinetics of Multiple Doses of Oral TAK-831 in Adults With Friedreich Ataxia | COMPLETED | PHASE2 |
| NCT06953583 | A Study to Learn More About the Effects and Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old (BRAVE) | RECRUITING | PHASE3 |
| NCT06447025 | An Open Label Extension Study of CTI-1601 in Subjects With Friedreich's Ataxia | ENROLLING_BY_INVITATION | PHASE2 |
| NCT06623890 | A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it by Their Own Doctors | RECRUITING | — |
| NCT03090789 | FA Clinical Outcome Measures | ACTIVE_NOT_RECRUITING | — |
| NCT04577352 | A Study to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Participants With Friedreich Ataxia | COMPLETED | PHASE2/PHASE3 |
| NCT02255435 | A Study to Learn About the Effects and Safety of RTA 408 (Omaveloxolone) in People Aged 16 to 40 With Friedreich's Ataxia | COMPLETED | PHASE2 |